NAD+ – Coenzyme, Function and Importance

What is NAD+?

NAD+, or Nicotinamide Adenine Dinucleotide, is a coenzyme found in virtually all living cells. It belongs to the group of pyridine nucleotides and plays a fundamental role in numerous biological processes, most notably energy metabolism and cellular repair. NAD+ exists in two primary forms: the oxidized form (NAD+) and the reduced form (NADH). The cycling between these two forms is critical for electron transport within the cell.

Mechanism of Action

NAD+ acts as an electron carrier in biochemical reactions. It accepts electrons and hydrogen ions, becoming reduced to NADH. This NADH then releases the stored energy within the mitochondrial electron transport chain (respiratory chain), enabling the production of ATP — the primary energy currency of the cell.

In addition, NAD+ is an essential substrate for the following enzyme classes:

• Sirtuins (SIRT1–SIRT7): NAD+-dependent deacetylases that regulate gene expression, cellular aging, inflammatory responses, and metabolic processes.
• PARP Enzymes (Poly-ADP-Ribose Polymerases): These enzymes consume NAD+ during DNA damage repair and play a key role in protecting the genome.
• CD38 and CD157: Ectoenzymes that use NAD+ to produce cyclic ADP-ribose, a signaling molecule involved in intracellular calcium release.

Biological Significance

Energy Metabolism

During glycolysis, the citric acid cycle, and fatty acid oxidation, NAD+ is reduced to NADH. The resulting NADH then delivers energy to the mitochondrial respiratory chain to drive ATP synthesis. Without sufficient NAD+, cellular energy production would be severely compromised.

DNA Repair and Cell Health

PARP enzymes depend on NAD+ to detect and repair damaged DNA. Low NAD+ levels can therefore reduce the DNA repair capacity of cells and contribute to the accumulation of genetic damage over time.

Cellular Aging (Senescence) and Longevity

As the body ages, NAD+ levels decline significantly. This decline has been linked to age-related conditions including neurodegenerative diseases, cardiovascular disease, and metabolic disorders. Sirtuins, well known for their role in extending lifespan in model organisms, require NAD+ for their enzymatic activity.

Immune Function and Inflammation

NAD+ and its metabolites influence immune cells and inflammatory signaling pathways. Adequate NAD+ levels support a balanced immune response and may help regulate chronic inflammation.

NAD+ Precursors and Supplementation

Because NAD+ itself is poorly absorbed by cells, research and commercially available supplements focus primarily on precursor molecules that are converted into NAD+ within the body:

• Niacin (Nicotinic Acid, Vitamin B3): One of the oldest and best-known NAD+ precursors.
• Nicotinamide (NAM): Another form of Vitamin B3 that is directly converted to NAD+.
• Nicotinamide Riboside (NR): A newer precursor with good bioavailability, currently under investigation in clinical trials.
• Nicotinamide Mononucleotide (NMN): Another well-studied precursor that is directly converted to NAD+ and has shown promising results in numerous animal studies.

Research into NAD+ supplementation in humans is still at an early stage. Some clinical studies show promising results in terms of raising NAD+ levels, but further long-term studies are needed to conclusively establish therapeutic effects.

Clinical Relevance and Research

NAD+ is the subject of intensive biomedical research. Potential clinical applications include:

• Age-related diseases and anti-aging strategies
• Neurodegenerative diseases (e.g., Alzheimer disease, Parkinson disease)
• Metabolic disorders (e.g., type 2 diabetes mellitus)
• Cardiovascular disease
• Protection against chemotherapy-related side effects

It is important to emphasize that NAD+ supplementation is currently not an approved medication. Individuals considering supplementation should always seek medical advice from a qualified healthcare professional.

References

1. Verdin E. - NAD+ in aging, metabolism, and neurodegeneration. Science, 350(6265), 1208-1213 (2015). https://doi.org/10.1126/science.aac4854
2. Yoshino J., Baur J.A., Imai S.I. - NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metabolism, 27(3), 513-528 (2018). https://doi.org/10.1016/j.cmet.2017.11.002
3. Cantó C., Menzies K.J., Auwerx J. - NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus. Cell Metabolism, 22(1), 31-53 (2015). https://doi.org/10.1016/j.cmet.2015.05.023